SMTL ID : 4lxd.1

Bcl_2-Navitoclax Analog (without Thiophenyl) Complex

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

1 x 1XV: 4-(4-{[4-(4-chlorophenyl)-5,6-dihydro-2H-pyran-3-yl]methyl}piperazin-1-yl)-N-{[3-nitro-4-(tetrahydro-2H-pyran-4-ylamino)phenyl]sulfonyl}benzamide(Non-covalent)

1XV.1: 20 residues within 4Å: Chain A: A.59, D.62, F.63, Y.67, D.70, F.71, M.74, V.92, E.95, L.96, N.102, W.103, G.104, R.105, V.107, A.108, F.112, V.115, F.157, Y.161 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:Y.67, A:M.74, A:V.92, A:R.105, A:F.112, A:Y.161 Hydrogen bonds: A:N.102, A:N.102, A:G.104 Water bridges: A:E.95, A:W.103, A:Y.161, A:Y.161 Salt bridges: A:D.70

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Souers, A.J. et al., ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. NAT.MED. (N.Y.) (2013)

Release Date

2013-08-14

Peptides

Apoptosis regulator Bcl-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Apoptosis regulator Bcl-2

Related Entries With Identical Sequence